Symptom Questionnaire and Laboratory Findings in Subjects with Airflow Limitation: a Nation-wide Survey |
Hwang, Yong Il
(On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Kim, Young Chul (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Lee, Jae Ho (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Kang, Min Jong (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Kim, Dong Gyu (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Kim, Soo Ock (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Jang, Tae Won (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Lee, Min Ki (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Ahn, Youngsoo (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Yoo, Jee Hong (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) Jung, Ki-Suck (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases) |
1 | Murray CJ, Lopez AD. Evidence-based health policy-- lessons from the Global Burden of Disease Study. Science 1996;274:740-3 DOI ScienceOn |
2 | Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease. Lancet 1997;349:1436-42 DOI ScienceOn |
3 | Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46 DOI ScienceOn |
4 | Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364:613-20 DOI ScienceOn |
5 | John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest 2005;127:825-9 DOI ScienceOn |
6 | Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survery. Am J Respir Crit Care Med 2005;172:842-7 DOI ScienceOn |
7 | National Heart, Lung, and Blood Institute and World Health Organization. Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda, MD, USA: National Heart, Lung, and Blood Institute, National Institutes of Health; 2006. [cited 25 January 2007]. Available from: http:// www.goldcopd.com |
8 | Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: 2486-97 DOI ScienceOn |
9 | Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007;29:923-9 DOI ScienceOn |
10 | Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005;2:8-11 DOI ScienceOn |
11 | Calverley PM. COPD: early detection and intervention. Chest 2000;117:365S-71S DOI ScienceOn |
12 | Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370:797-9 DOI ScienceOn |
13 | Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504 DOI ScienceOn |
14 | Choi JK, Paek D, Lee JO. Normal predictive values of spirometry for Korean population. Tuberc Respir Dis 2005;58:230-42 DOI |